Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
This piece covers core Zero Based Budgeting concepts in plain language, highlighting how to apply them to real-life budgeting scenarios.
15,763 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Lucid faces a pivotal year as production scales and capital needs rise. This guide outlines plausible paths for where...
As driverless taxis move from test zones to real streets, Alphabet and its Waymo unit sit at the center of the race. ...
CoreWeave’s latest trading session highlighted the tension between high-growth AI clouds and the realities of funding...
A major institutional stake in TTMI has sparked fresh debates about the stock's risk and reward. This guide breaks do...
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
Institutional moves can reveal where smart money is flowing. Learn why highmark wealth management buys Axogen stock, ...
As MercadoLibre broadens beyond e-commerce, the mercado pago growth engine becomes a pivotal piece of the puzzle. Thi...
Lowe’s beat on near-term earnings but issued a muted FY26 outlook, sending its stock lower while TJX jumped on strong...
In today’s Morning Minute, Circle earnings take center stage as crypto markets rally. Stablecoins anchor liquidity wh...
When tech stocks wobble, the DOW often holds steady. This article explains why the DOW can beat Nasdaq today, what dr...
A day of mixed signals, with Nvidia’s surge fading and tech shares pulling the Nasdaq and S&P 500 lower. Here’s what ...